Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 207.70 | (64.42) | (11.14)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 325.27 | (8.26) | (2.93)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 461.09 | 44.40 | 10.17¢ | 12.3 | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Geron explains setback on stem cell study | 28-Aug-2009 | BayArea.com |
Geron sees progress in stem-cell therapy | 27-Aug-2007 | BayArea.com |
Stock Ticker | 12-Jun-2007 | BayArea.com |
Currency | US Dollars |
Share Price | $ 1.27 |
Change Today | $ 0.02 |
% Change | 1.60 % |
52 Week High | $1.34 |
52 Week Low | $1.25 |
Volume | 6,385,232 |
Shares Issued | 186.46m |
Market Cap | $236.80m |
Beta | 0.00 |
RiskGrade | 277 |
Strong Buy | 3 |
Buy | 3 |
Neutral | 3 |
Sell | 1 |
Strong Sell | 0 |
Total | 10 |
Time | Volume / Share Price |
16:00 | 435,245 @ $1.27 |
15:59 | 200 @ $1.27 |
15:59 | 361 @ $1.28 |
15:59 | 200 @ $1.27 |
15:59 | 200 @ $1.28 |
You are here: research